Cancer Research UK logo.
SearchDonate
  • Search

A trial of nivolumab, ipilimumab and chemotherapy for advanced lung cancer (CA209227)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Results

Phase:

Phase 3

Details

This trial was for people with non small cell lung cancer (NSCLC) that had spread to another part of the body.

This trial was open for people to join between August 2015 and November 2016.

These results were published in 2018.

Recruitment start: 1 August 2015

Recruitment end: 15 August 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr David Spicer

Supported by

Bristol-Myers Squibb

Experimental Cancer Medicine Centre (ECMC)

Ono Pharmaceutical Co. Ltd

Last reviewed: 8 July 2019

CRUK internal database number: 14094

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.